Cart is empty Mefenamic acid, a common anti-inflammatory drug already approved for pain management, has been found to significantly reduce the formation of a toxic compound known as p-cresol sulfate in people with kidney disease with a minimal dose.
Mefenamic acid, a common anti-inflammatory drug already approved for pain management, has been found to significantly reduce the formation of a toxic compound known as p-cresol sulfate in people with kidney disease with a minimal dose.
Leave A Comment